All WHO Member States adopted the Global Action Plan on Antimicrobial Resistance in 2015 which identifies five areas of action needed to tackle antimicrobial resistance: improving awareness, increasing surveillance and monitoring, improve infection prevention, optimize the use of antimicrobials and develop new antibiotics, vaccines and diagnostics.
With the onset and fast pace of globalization, global governance helps address issues that affect all countries regardless of borders. Antibiotic resistance is one such threat to the security of people all over the world.
Globally coordinated governance on antimicrobial resistance ensures a sustainable response that takes into account the needs, challenges and priorities of low- and middle-income countries. Click to learn more.
Global policies are often used in advocacy initiatives to remind countries of their global commitment to antimicrobial resistance and to hold governments accountable to track progress towards managing these commitments.
The ReAct Toolbox aims to assist you that are engaged in policy work – both in human and animal health – to help action on antimicrobial resistance.
Meeting report – A planetary threat but a financing orphan
How should needed work on antimicrobial resistance be funded? Read meeting report from workshop with experts on antimicrobial resistance and global health. There is currently no ‘go-to-place’ for funding the implementation of National Action Plans on AMR and this is a serious concern.The report is prepared by ReAct and the Dag Hammarskjöld Foundation. Read full report: Antimicrobial Resistance and sustainable development: A planetary threat but a financing orphan (PDF).
A new study in The Lancet Infectious Diseases reports an increase in the burden of antibiotic resistant infections in the EU/EEA. Now 33000 people die annually from antibiotic resistant bacterial infections, an increase from 10 years ago. In Europe, the burden is actually comparable to that from HIV, TB and influenza combined.
Knowledge is critical for good policy and practical work. In the Global Action Plan on AMR adopted by WHO in 2015, strategic objective 2 is to “Strengthen the knowledge and evidence base through surveillance and research”. But how can this be done in countries that lack funds and technical capacity?
In May of 2018, the WHO released the first-ever list of essential diagnostics to improve diagnosis and treatment outcomes to the delight of many champions of antimicrobial resistance across the globe. In Africa, the release of this list was particularly exciting to one doctor in Nairobi, Kenya, who has long been an advocate for the development of such a list.
Stefan Swartling Peterson, Chief of Health at Unicef, sees strong health systems as key to prevent infections and spread of antibiotic resistance. “Strong health systems, where a midwife is able to wash her hands before she delivers you, but also where drugs and supplies are available and the health worker has been paid and supervised are key”, he says.Read interview where Professor Swartling Peterson elaborates on the access-excess relation to antibiotics, implementation research methods, strong health systems and future work of Unicef.
As we celebrate the 90th anniversary of the discovery of penicillin, it is appropriate to take a look at the current state of modern medicine since the discovery penicillin and the other antibiotics that followed. Here are seven ways that penicillin changed modern medicine.
According to a recent publication in the Proceedings of the National Academy of Science, global antibiotic consumption in humans has increased dramatically from 2000 to 2015. The study rings a bell on the complex challenges posed by underuse, misuse and overuse of antibiotics.
Dr. Nithima Sumpradi from the Thai Food and Drug Administration was one of the key researchers responsible for the Antibiotic Smart Use project in Thailand. Here she explains the program more in detail, what it has achieved and reflects over lessons learned in the process.